COA6 and neoplasm: Blockade of β-adrenergic receptor signalling reverts endothelialcell metabolism from aerobic glycolysis towards oxidative phosphorylationthrough cytochrome C oxidase assembly factor 6 (Coa6) activity, therebyinhibiting angiogenesis and curtailing tumour progression [165].